Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-034268
Filing Date
2017-02-08
Accepted
2017-02-08 12:39:21
Documents
4
Effectiveness Date
2017-02-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d346732ds8.htm S-8 37492
2 EX-5.1 d346732dex51.htm EX-5.1 7965
3 EX-23.2 d346732dex232.htm EX-23.2 1519
4 GRAPHIC g346732g73b62.jpg GRAPHIC 3323
  Complete submission text file 0001193125-17-034268.txt   52670
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-215959 | Film No.: 17581669
SIC: 2835 In Vitro & In Vivo Diagnostic Substances